抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn)：

1. TRAF2和NCK激酶相互作用蛋白抗體費(fèi)用 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；

2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來(lái)篩選最適條件；

3.用NHSB量過(guò)量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活；

4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等；

5.當(dāng)游離ε-氨基(賴(lài)氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性；

6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合；

7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用；

8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。

產(chǎn)品訂購(gòu)信息：
英文名稱(chēng)  Anti-TNIK 

中文名稱(chēng)   TRAF2和NCK激酶相互作用蛋白抗體費(fèi)用 

別    名  Traf2 and NCK interacting kinase; 1500031A17RIK; 4831440I19RIK; AI451411; C530008O15Rik; C630040K21RIK; KIAA0551; MGC189819; MGC189859; RGD1561817; TNIK.

濃    度   1mg/1ml

規(guī) 格  0.2ml/200μg

抗體來(lái)源   Rabbit

克隆類(lèi)型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Chicken, Pig, Cow, Horse, Rabbit 

產(chǎn)品類(lèi)型   一抗  

研究領(lǐng)域    免疫學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 激酶和磷酸酶

蛋白分子量  predicted molecular weight: 150kDa

性    狀   Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from human TNIK 

亞    型   IgG

純化方法   affinity purified by Protein A

儲(chǔ) 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

TRAF2和NCK激酶相互作用蛋白抗體費(fèi)用 產(chǎn)品應(yīng)用    WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 TNIK is a MSN protein kinase that interacts with both TNF receptor-associated factor 2 (TRAF2) and the adapter protein NCK. The protein has been shown to activate the c-Jun N-terminal kinase pathway when over expressed in Phoenix-A cells. TNIK has been shown to phosphorylate gelsolin, the principal intracellular and extracellular actin-severing protein, in vitro. This and evidence from mutational studies suggest that TNIK functions in the regulation of the cytoskeleton. Northern analysis indicates TNIK expression in human heart, skeletal muscle, and brain, with lower levels of expression in kidney, liver, lung, and pancreas. ESTs have been isolated from human tissue libraries, including normal amnion, gallbladder and skin.

Function : Serine/threonine kinase that acts as an essential activator of the Wnt signaling pathway. Recruited to promoters of Wnt target genes and required to activate their expression. May act by phosphorylating TCF4/TCF7L2. Appears to act upstream of the JUN N-terminal pathway. May play a role in the response to environmental stress. Part of a signaling complex composed of NEDD4, RAP2A and TNIK which regulates neuronal dendrite extension and arborization during development. More generally, it may play a role in cytoskeletal rearrangements and regulate cell spreading. Phosphorylates SMAD1 on Thr-322.

Subunit : Interacts (via the CNH domain) with RAP2A (GTP-bound form preferentially); the interaction is direct and required for the activation of TNIK by RAP2A. Interacts with NEDD4; recruits RAP2A to NEDD4. Interacts with TRAF2 and NCK. Interacts with TCF7L2/TCF4 and CTNNB1; the interaction is direct. Interacts with TANC1.

Subcellular Location : Nucleus. Cytoplasm. Recycling endosome. Cytoplasm, cytoskeleton. Note=Associated with recycling endosomes and the cytoskeletal fraction upon RAP2A overexpression.

Tissue Specificity : Expressed ubiquitously. Highest levels observed in heart, brain and skeletal muscle. Expressed in normal colonic epithelia and colorectal cancer tissues.

Post-translational modifications : Autophosphorylated. Autophosphorylation is activated by RAP2A and induces association to the cytoskeletal fraction.

Similarity : Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. STE20 subfamily.

Contains 1 CNH domain.

Contains 1 protein kinase domain.

抗體的鑒定：

1）TRAF2和NCK激酶相互作用蛋白抗體費(fèi)用 抗體的效價(jià)鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來(lái)鑒定。

2）抗體的特異性鑒定：抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力?？贵w的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來(lái)表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。 

如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無(wú)窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。

3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫(kù)侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol。抗體親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。

TTF-1 (Thyroid Transcription Factor-1) 甲狀腺核轉(zhuǎn)錄因子-1抗原Multi-class antibodies規(guī)格： 0.5mg

Anti-Caspase-1(actived) 天冬氨酸-胱氨酸特異性蛋白酶家族抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh PD-1/CD279 程序性死亡1抗體 規(guī)格 0.1ml

FCGR2B Kit Human 人 CD32b / FCGR2B ELISA配對(duì)抗體 ELISA

TSBP 英文名稱(chēng)： 特異蛋白抗體 0.2ml

Alpha s2 Casein 英文名稱(chēng)： α-s2酪蛋白抗體 0.2ml

Anti-Caspase-1(actived) 天冬氨酸-胱氨酸特異性蛋白酶家族抗體Multi-class antibodies規(guī)格： 0.1ml

EPOR ELISA Kit 大鼠紅細(xì)胞生成素受體Multi-class antibodies規(guī)格： 48T

Anti-APS(Ser598)/FITC 熒光素標(biāo)記磷酸化APS抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh FAM3B/PANDER *衍生因子抗體 規(guī)格 0.2ml

ALP ELISA Kit 大鼠堿性磷酸酶 96T

Phospho-MAP3K8 (Thr290) 英文名稱(chēng)： 磷酸化原活化蛋白激酶激酶8抗體 0.1ml

Annexin A10 英文名稱(chēng)： 膜粘連蛋白10抗體 0.1ml

Anti-APS(Ser598)/FITC 熒光素標(biāo)記磷酸化APS抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Anti-VSIG4 /FITC 熒光素標(biāo)記T淋巴細(xì)胞負(fù)調(diào)節(jié)蛋白之一抗體IgGMulti-class antibodies規(guī)格： 0.2ml

CK19 細(xì)胞角蛋白19多肽抗原Multi-class antibodies規(guī)格： 0.5mg

鼠抗人癌胚抗原單克隆抗體(包被) Anti-CEA 0.1ml

Sprouty1 英文名稱(chēng)： 軟脂酰化磷蛋白Sprouty1抗體 0.1ml

eRF1 英文名稱(chēng)： 真核肽鏈釋放因子1抗體 0.2ml

Rhesus antibody Rh Phospho-Gab1 (Tyr659) 磷酸化接頭蛋白Gab 1抗體 規(guī)格 0.1ml

CK19 細(xì)胞角蛋白19多肽抗原Multi-class antibodies規(guī)格： 0.5mg

大鼠膜聯(lián)蛋白Ⅴ(ANX-Ⅴ)ELISA試劑盒 ，英文名： ANX-Ⅴ ELISA Kit

人細(xì)胞間粘附分子3(ICAM-3/CD50)ELISA檢測(cè)試劑盒Humaniercellularadhesionmolecule3,ICAM-3ELISAKit 96T/48T

羊α晶體B鏈(CRYAB)免疫試劑盒 Sheep Alpha-crystallin B chain,CRYAB ELISA kit

CLIAKitforPAI-1ELISAKit大鼠纖溶酶原激活物抑制因子1規(guī)格：48T/96T

水蛭素(hirudin)活性熒光定量檢測(cè)試劑盒20次

ELISAKitCPN10人伴侶蛋白10規(guī)格：48T/96T

大鼠叉頭蛋白P3(FOXP3)ELISA試劑盒 96T/48T 試劑盒 組裝/原裝

人免疫球蛋白E(IgE)免疫試劑盒 human Immunoglobulin E,IgE ELISA Kit

MouseUreaplasmaurealyticumaibody,UU-AbELISAKit小鼠解脲脲原體抗體(UU-Ab)ELISA試劑盒規(guī)格：96T/48T

石蠟切片組織CASPASE-1蛋白表達(dá)NBT顯色光學(xué)顯微鏡檢測(cè)試劑盒10/20次

humanProstaglandinE1,PG-E1ELISA試劑盒人素E1(PGE1)ELISA試劑盒規(guī)格：96T/48T

Humahymidylatesyhetase,TSELISAKit人胸苷酸合成酶(TS)ELISA試劑盒規(guī)格：96T/48T

TRAF2和NCK激酶相互作用蛋白抗體費(fèi)用 大鼠淀粉樣蛋白β1-42(Aβ1-42)ELISA試劑盒 ，英文名： Aβ1-42 ELISA Kit

Ierleukin 1 soluble receptor I (IL-1sR I) of rat ELISA Kit 大鼠白介素1可溶性受體Ⅰ(IL-1sRⅠ)ELISA試劑盒

Ratmaixmetalloproteinase1,MMP-1ELISAkit 大鼠基質(zhì)金屬蛋白酶1(MMP-1)ELISA試劑盒 96T/48T 進(jìn)口分裝

CLIAKitforCyt-CELISAKit大鼠細(xì)胞色素C規(guī)格：48T/96T

細(xì)胞色素P450亞酶3A4(TESTOSTERONE)活性高效液相色譜法(HPLC)定量檢測(cè)試劑盒20次

RatGamma-aminobyricacid,GABAELISAKit大鼠γ氨基(GABA)ELISA試劑盒規(guī)格：96T/48T